Skip to main content
. 2021 Jun;10(6):2882–2894. doi: 10.21037/tcr-20-1751

Figure 5.

Figure 5

Molecular mechanisms underlying the effects of SLC26A6. (A) Genetic alterations of SLC26A6 in HCC patients from TCGA dataset. (B) Pathway Commons analysis showing the molecular interaction network of SLC26A6 in three different ways (control its expression, binding and catalysis). (C) MiRNAs predicted to target SLC26A6 in conserved site using Targetscan. (D) GO analysis of SLC26A6-associated genes in HCC tissues. (E) KEGG pathway analysis of SLC26A6-associated genes in HCC tissues. HCC, hepatocellular carcinoma.